BiondVax Pharmaceuticals Ltd. Announces Closing of U.S. Initial Public Offering
15 mai 2015 12h13 HE
|
BiondVax Pharmaceuticals Ltd.
NES ZIONA, Israel, May 15, 2015 (GLOBE NEWSWIRE) -- BiondVax Pharmaceuticals Ltd. (Nasdaq:BVXV) (Nasdaq:BVXVW), a clinical stage biopharmaceutical company focused on developing and commercializing...
BiondVax Pharmaceuticals Ltd. Announces Pricing of U.S. Initial Public Offering of 1,910,000 ADSs and Warrants to Purchase 1,910,000 ADSs
11 mai 2015 20h12 HE
|
BiondVax Pharmaceuticals Ltd.
RECHOVOT, Israel, May 11, 2015 (GLOBE NEWSWIRE) -- BiondVax Pharmaceuticals Ltd (Nasdaq:BVXV) (Nasdaq:BVXVW), a clinical stage biopharmaceutical company focused on developing and commercializing...